Release Date: 24/08/09 10:31 Summary: Open Briefing SKILLED. Capital Raising and Outlook Price Sensitive: Yes Download Document 65.33KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status